Comment on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two Overtreatments Compared

Detalles Bibliográficos
Autor principal: Mroczkowski, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431424/
https://www.ncbi.nlm.nih.gov/pubmed/37601467
http://dx.doi.org/10.1097/AS9.0000000000000295
_version_ 1785091198071865344
author Mroczkowski, Paweł
author_facet Mroczkowski, Paweł
author_sort Mroczkowski, Paweł
collection PubMed
description
format Online
Article
Text
id pubmed-10431424
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-104314242023-08-18 Comment on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two Overtreatments Compared Mroczkowski, Paweł Ann Surg Open Letter to the Editor Wolters Kluwer Health, Inc. 2023-06-15 /pmc/articles/PMC10431424/ /pubmed/37601467 http://dx.doi.org/10.1097/AS9.0000000000000295 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Letter to the Editor
Mroczkowski, Paweł
Comment on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two Overtreatments Compared
title Comment on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two Overtreatments Compared
title_full Comment on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two Overtreatments Compared
title_fullStr Comment on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two Overtreatments Compared
title_full_unstemmed Comment on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two Overtreatments Compared
title_short Comment on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two Overtreatments Compared
title_sort comment on “neoadjuvant chemotherapy with capox versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (convert): initial results of a phase iii trial” by mei et al.: two overtreatments compared
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431424/
https://www.ncbi.nlm.nih.gov/pubmed/37601467
http://dx.doi.org/10.1097/AS9.0000000000000295
work_keys_str_mv AT mroczkowskipaweł commentonneoadjuvantchemotherapywithcapoxversuschemoradiationforlocallyadvancedrectalcancerwithuninvolvedmesorectalfasciaconvertinitialresultsofaphaseiiitrialbymeietaltwoovertreatmentscompared

Ejemplares similares